Materiality Under the False Claims Act: What the Government Knew When It Paid

Whistleblower Justice Network

False Claims Act materiality asks whether a false statement or concealed fact could influence money the government pays or receives. What the government knew when it paid matters. For someone in billing, compliance or contract management, the useful evidence may sit between the claim the government received and the information the company kept inside. The company may point to continued payment. You may know what never accompanied the bill.

What Does Materiality Mean Under the False Claims Act?

A falsehood is material when it could influence what the government pays or receives. The Supreme Court’s 2016 decision involving Universal Health Services makes the question concrete: would a reasonable recipient attach importance to the information when deciding what to do? Information can also matter because the company knows this particular recipient considers it important.

The Supreme Court calls this a demanding standard: the evidence must connect the falsehood to the government’s decision. What was the government buying? What qualifications, product characteristics or eligibility requirements went to the heart of that purchase? A requirement expressly labeled a condition of payment carries weight, but the label does not settle the question. The government’s legal power to refuse payment does not settle it either. The evidence has to show why this requirement mattered to the decision.

The same definition covers money owed to the government. A false record that conceals an obligation to pay, including customs duties, can support a reverse false claim. The connection is to money the government should receive.

The Universal Health Services case arose from allegations about a Massachusetts mental health clinic’s Medicaid claims. The whistleblowers alleged that the clinic used billing codes and provider identifiers representing particular services and professional qualifications while concealing serious licensing and supervision failures. The Supreme Court recognized that specific claims about services can become misleading when the provider leaves out facts central to those services. The qualifications of the people delivering the care were part of what Medicaid was paying for.

That is how an omitted fact can carry the weight of a false statement. The billing description tells a reassuring story while leaving out the part that would change its meaning.

Does Continued Government Payment Defeat Materiality?

No. Continued payment does not automatically defeat materiality. But if the government knew of the violation and paid the claim in full anyway, that is powerful evidence that the requirement did not matter to payment. Consistent refusal to pay for the same violation points the other way.

The distinction is between having the authority to stop payment and treating the information as important enough to affect payment. Policies, claim denials, eligibility decisions and communications about the requirement can show that connection. The sequence matters too: payment before the agency learned the facts tells a different story from payment after it investigated them.

What Did the Government Actually Know?

Hearing an accusation is not the same as knowing the facts. Actual knowledge turns on what the government understood about the violation. The responsible office matters as much as the date on the letter.

An investigator, a regulator and the office deciding payment can have different information. We connect what each received to the decision it could make: approval, eligibility, reimbursement or enforcement. A complaint sent to one office and a payment issued by another need that connection before either tells the whole story.

The government’s decision to join a whistleblower case answers a different question from whether it would pay with full knowledge of the conduct. In its Care Alternatives opinion, the Third Circuit said the government’s choice not to join tells us little about whether the falsehood mattered to payment. We do not treat a government check as an endorsement of everything hidden behind it.

The Payment Trail Starts Before the Invoice

A falsehood can affect payment through a product’s approval, a provider’s qualifications or a patient’s eligibility before anyone submits an invoice. The company’s records and the government’s payment records may therefore show different parts of the same transaction.

The Congressional Research Service’s 2009 report, Qui Tam: The False Claims Act and Related Federal Statutes, explains that the law reaches qualifying claims paid through recipients of federal funds, as well as claims presented directly to the government. That matters when the manufacturer supplies a product, another business bills for it and a federal program funds the payment. The relevant false information may enter well before the final bill.

In prescription-drug reimbursement, Medicare Part D works through private plan sponsors, which contract with pharmacies, sometimes through pharmacy benefit managers. The pharmacy’s reported price can move through that chain. Knowing which business received the price is part of knowing how it influenced federal spending.

For an insider considering reporting False Claims Act fraud, that gap can be the center of a qui tam case. We connect the representation, the underlying records and the payment decision, including who knew about the discrepancy inside the business.

Why Do Courts Reach Different Results on Materiality?

Different evidence about what the agency knew can produce different results. Gilead involved disputed knowledge about drug manufacturing. Care Alternatives involved medical records Medicare did not receive with the claims. Trinity involved an agency that examined the disputed product changes and maintained its approval.

Gilead Sciences and the Unresolved Facts Behind Drug Approval

Former employees alleged that Gilead Sciences used an unapproved source of an active ingredient in HIV drugs, concealed where it came from and supplied false or incomplete testing information to the Food and Drug Administration. The manufacturing detail mattered. A drug approval identifies the facilities and manufacturing process, not just the name on the bottle. The alleged substitution therefore reached the basis on which the government funded the drugs.

Gilead pointed to continued approval and government payment. The court explained that the agency could have reasons to retain an approval apart from the payment issue. It also noted that Gilead had stopped using the disputed supplier. Paying for compliant drugs afterward carried a different meaning from continuing to pay for drugs with the alleged defects.

What the government knew, and when, remained disputed. In its 2017 Gilead Sciences decision, the Ninth Circuit allowed the allegations to proceed.

Care Alternatives and the Medical Records Medicare Did Not Receive

Former employees alleged that Care Alternatives billed Medicare for hospice care without adequate clinical documentation supporting patients’ terminal diagnoses. The Third Circuit’s 2023 decision restored the case because the lower court had treated government inaction as decisive while overlooking other evidence.

Care Alternatives emphasized physician signatures and compassionate care. The court focused on what the documentation requirement did: it helped establish that patients actually qualified for the Medicare hospice benefit. A signature needed a medically supported basis. Providing care did not answer the eligibility question.

The lower court had reasoned that the government could see the documentation defects in what the company submitted. But hospice providers kept the certifications and supporting clinical records in patients’ files. They did not send those records with every payment claim. The court rejected the assumption that reviewing a reimbursement claim gave Medicare actual knowledge of the missing support.

The opinion also described a joint investigation by the Justice Department and the Department of Health and Human Services’ Office of Inspector General. Even with that investigation, the extent and timing of government knowledge remained uncertain. The claims at issue had already been paid when investigators sought the records.

An internal audit and employee testimony supported the whistleblowers’ allegations of widespread documentation problems. The court ruled that a jury could find those alleged failures material after weighing the evidence together. Continuing to pay was evidence to consider, alongside the records showing what those payments bought.

Trinity Industries and an Agency That Examined the Product

The Trinity Industries case concerned changes to highway guardrail end terminals and whether the company had disclosed them to the Federal Highway Administration. The payment arrangement made that agency’s response central. The government reimbursed states for qualifying installations, and federal highway approval determined reimbursement eligibility. The whistleblower presented the disputed design changes to the agency. It examined the allegations, met with the parties and confirmed continued eligibility.

In its 2017 Trinity Industries decision, the Fifth Circuit overturned the trial judgment because the agency knew about the disputed changes and continued reimbursement, leaving materiality unproved. Trinity also continued using the changed design. That separated this evidence from Gilead’s switch away from the disputed supplier. The contrast runs through the payment records: unresolved knowledge in the drug case, an unsupported assumption about Medicare’s access to hospice records, and an agency’s affirmative examination of the guardrail changes.

What the Company Knew Is a Separate Question

Knowledge asks what the company understood when it submitted the claim. Materiality asks what the falsehood meant to payment. The same email can illuminate both, but each needs its own evidence.

In the 2023 Supreme Court decision involving SuperValu and Safeway, whistleblowers alleged that the pharmacies reported higher usual and customary prices to reimbursement programs while charging customers lower discounted prices. Their evidence included notices explaining how discounts affected the reported price and internal concerns about payers discovering those discounts.

The Court held that the companies’ understanding and beliefs when they submitted claims mattered. A different interpretation offered afterward could not erase what they believed at the time. That decision addressed knowledge. The connection between the reported price and reimbursement still belongs in the payment analysis.

We look beyond the last invoice to the falsehood that secured the business. A contract obtained through a material falsehood can affect later payment claims even where the invoices accurately describe the work performed.

The Records That Explain Why the Falsehood Mattered

The strongest account connects the hidden fact to the decision it could influence. A payment policy explains the requirement. An approval file shows which product or provider qualified. Clinical records, test results or pricing records show what the company actually supplied or represented. Agency communications and payment histories show what happened when the information reached the government.

We examine those records together with the insider who understands the business. The question is specific: how did this falsehood affect what the government agreed to fund, and what did each side know? That gives the materiality analysis a transaction, a payer and evidence behind it. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.

When You Know What the Payment Left Out

If you know the company concealed information that mattered to money the government paid or was owed, speak with our whistleblower experts about the claim and what sat behind it. We work with you to build your strongest False Claims Act whistleblower case and bring in whistleblower lawyers who understand your industry’s payments and obligations to the government. We stay beside you as the evidence becomes a case.

WHISTLEBLOWER JUSTICE NETWORK CAN HELP YOU
Make a difference.
Whistleblower Justice NetworkReport Fraud
100% CONFIDENTIALFREE CONSULTATION24 / 7 / 365